Skip to main content
. 2016 Nov 1;194(9):1104–1115. doi: 10.1164/rccm.201602-0220OC

Table 1.

Demographics and Clinical Parameters Stratified by Healthy Control Subjects and Outpatients/Inpatients with Respiratory Syncytial Virus Infection (N = 132)

  Healthy (n = 26) Outpatients (n = 22) Inpatients (n = 84) P Value
Demographic characteristics        
 Age, mo 6.6 (2.0–10.2) 7.2 (5.0–12.2) 2.6 (1.4–4.9) <0.0005*
 Male sex 19 (73.1) 12 (54.5) 50 (59.5) 0.36
 Breastfeeding 5/17 (29.4) 2/22 (9.1) 19/82 (23.2) 0.25
 Antibiotics 0 (0.0) 4 (18.2) 39 (46.4) <0.0005
 Days of antibiotics before sampling N/A § 1.0 (1.0–2.0) N/A
 Days of symptoms at enrollment N/A 3.5 (2.0–5.5) 5.0 (4.0–6.0) 0.03||
Disease severity        
 Length of stay, d N/A N/A 3.2 (2.0–5.5) N/A
 O2 requirement N/A 0 (0.0) 71 (84.5) <0.0005
 CDSS        
  Mild N/A 21 (95.5) 18 (21.4)  
  Moderate N/A 1 (4.5) 41 (48.8)  
  Severe N/A 0 (0.0) 25 (29.8) <0.0005
 PICU admission N/A N/A 35 (41.7) N/A
White blood cells/μl 7.9 (6.9–9.4) 10.0 (7.3–11.8) 11.8 (9.0–14.7) <0.0005*
 Neutrophils, % 21.0 (13.5–27.5) 26.5 (19.3–45.8) 35.5 (27.8–49.3) <0.0005*
 Lymphocytes, % 67.0 (59.8–76.5) 57.0 (35.0–70.5) 50.5 (39.0–61.0) <0.0005*
 Monocytes, % 7.0 (5.0–11.0) 12.0 (8.8–15.8) 12.0 (8.0–16.0) 0.001*

Definition of abbreviations: CDSS = clinical disease severity score, which ranks from 0–15 and is stratified in: mild (0–5), moderate (6–10), and severe (11–15) respiratory syncytial virus disease; N/A = not applicable; PICU = pediatric intensive care unit.

Data reported are median (interquartile range) or n (%). Statistically significant P values (P < 0.05) are shown in boldface.

*

Statistically significant differences between groups were calculated using Kruskal–Wallis test for continuous variables.

Statistically significant differences between groups were calculated using chi-square test for categorical data.

Statistically significant differences between groups were calculated using Fisher’s exact test for categorical data.

§

Four children received antibiotic treatment, 2, 10, 12, and 21 d before sampling.

||

Statistically significant differences between groups were calculated using Mann-Whitney test for continuous variables.

On twenty samples, no white blood cell count and differential was performed (2, 4, and 14 samples of healthy children, outpatients, and inpatients, respectively).